Outcome of allogeneic hematopoietic stem cell transplantation for follicular lymphoma relapsing after autologous transplantation: analysis of the Japan Society for Hematopoietic Cell Transplantation

被引：0

作者：

Masatoshi Sakurai

Takehiko Mori

Koji Kato

Minoru Kanaya

Shohei Mizuno

Souichi Shiratori

Toshio Wakayama

Naoyuki Uchida

Hikaru Kobayashi

Kohmei Kubo

Itsuto Amano

Takanori Ohta

Yasuhiko Miyazaki

Junya Kanda

Takahiro Fukuda

Yoshiko Atsuta

Eisei Kondo

机构：

[1] Keio University School of Medicine,Division of Hematology, Department of Medicine

[2] Kyushu University Graduate School of Medical Science,Department of Medicine and Biosystemic Science

[3] Oslo University Hospital,Department of Cancer Immunology, Institute for Cancer Research

[4] Hokkaido University Hospital,Department of Hematology

[5] Aichi Medical University,Division of Hematology, Department of Internal Medicine

[6] Shimane Prefectural Central Hospital,Department of Hematology and Oncology

[7] Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital,Department of Hematology

[8] Nagano Red Cross Hospital,Department of Hematology

[9] Aomori Prefectural Central Hospital,Department of Hematology

[10] Nara Medical University Hospital,Department of Respiratory Medicine and Hematology

[11] Kitakyushu City Hospital Organization,Department of Hematology

[12] Kitakyushu Municipal Medical Center,Department of Hematology

[13] Oita Prefectural Hospital,Department of Hematology and Oncology, Graduate School of Medicine

[14] Kyoto University,Hematopoietic Stem Cell Transplantation Division

[15] National Cancer Center Hospital,Department of Healthcare Administration

[16] Japanese Data Center for Hematopoietic Cell Transplantation,Department of Hematology

[17] Nagoya University Graduate School of Medicine,Division of Cancer Information and Control, Department of Prevention Medicine

[18] Kawasaki Medical School,Department of Hematology and Cell Therapy

[19] Aichi Cancer Center Hospital,Division of Hematology, Department of Internal Medicine

[20] Aichi Cancer Center Hospital,Department of Hematology

[21] Aichi Medical University,Department of Hematology

[22] Asahi General Hospital,Department of Hematology

[23] Ehime Prefectural Central Hospital,Department of Hematology and Oncology

[24] Hyogo Prefectural Amagasaki General Medical Center,Department of Hematology

[25] JA Aichi Konan Kosei Hospital,Department of Hematology

[26] Japanese Red Cross Kyoto Daiichi Hospital,Department of Hematology

[27] Japanese Red Cross Nagoya Daiichi Hospital,Division of Hematology

[28] Japanese Red Cross Osaka Hospital,Department of Hematology

[29] Jichi Medical University Saitama Medical Center,Department of Hematology

[30] Juntendo Nerima Hospital,Department of Hematology and Medical Oncology

[31] Juntendo University Urayasu Hospital,Department of Hematology and Immunology

[32] Kanagawa Cancer Center,Department of Hematology

[33] Kanazawa Medical University,Department of Hematology

[34] Kanazawa University,Hematology/Internal Medicine

[35] Kobe City Medical Center General Hospital,Department of Hematology and Oncology

[36] Koga Community Hospital,Department of Hematology

[37] Kyoto University,Department of Hematology

[38] Kyoto University,Department of Hematology and Oncology

[39] Matsue Red Cross Hospital,Department of Hematology and Oncology

[40] Mie University Graduate School of Medicine,Department of Hematology

[41] Nagoya University Graduate School of Medicine,Department of Hematopoietic Stem Cell Transplantation

[42] National Cancer Center Hospital,Department of Hematology and Clinical Research Institute

[43] National Cancer Center Hospital,Department of Hematology

[44] National Hospital Organization Kyushu Medical Center,Department of Hematologic Oncology

[45] National Hospital Organization Nagoya Medical Center,Department of Internal Medicine, Division of Hematology

[46] National Hospital Organization Shikoku Cancer Center,Department of Hematology and Oncology

[47] NHO Tokyo Medical Center,Department of Hematology

[48] Okinawa Chubu Hospital,Department of Hematology

[49] Osaka City University,Department of Hematology

[50] Osaka Gyoumeikan Hospital,Department of Oncology and Hematology

来源：

Bone Marrow Transplantation | 2021年 / 56卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1462 / 1466

页数：4

共 50 条

[31] Second allogeneic hematopoietic stem cell transplantation in patients with acute leukemia relapsed after allogeneic hematopoietic stem cell transplantation
Choi, Yunsuk
Choi, Eun-Ji
Lee, Jung-Hee
Lee, Kyoo-Hyung
Jo, Jae-Cheol
Park, Han-Seung
Lee, Yoo Jin
Seol, Miee
Lee, Young-Shin
Kang, Young-Ah
Jeon, Mijin
Lee, Je-Hwan
CLINICAL TRANSPLANTATION, 2021, 35 (03)
[32] Salvage Allogeneic Hematopoietic Cell Transplantation for Relapsed or Progressive Multiple Myeloma After Autologous Hematopoietic Cell Transplantation
Schneidawind, Dominik
Oehrlein, Katharina
Weisel, Katja C.
Faul, Christoph
Kanz, Lothar
Bethge, Wolfgang A.
BLOOD, 2012, 120 (21)
[33] Outcome of stem cell transplantation for Waldenstrom's macroglobulinemia: analysis of the Japan Society for Hematopoietic Cell Transplantation (JS']JSHCT) Lymphoma Working Group
Sakurai, Masatoshi
Mori, Takehiko
Uchiyama, Hitoji
Ago, Hiroatsu
Iwato, Koji
Eto, Tetsuya
Iwasaki, Hiromi
Kawata, Takahito
Takamatsu, Hiroyuki
Yamasaki, Satoshi
Takanashi, Minoko
Ichinohe, Tatsuo
Atsuta, Yoshiko
Suzuki, Ritsuro
ANNALS OF HEMATOLOGY, 2020, 99 (07) : 1635 - 1642
[34] Allogeneic hematopoietic stem cell transplantation
Faul, C.
ONKOLOGIE, 2012, 35 : 112 - 112
[35] Allogeneic hematopoietic stem cell transplantation
Kai, S
Hara, T
THERAPEUTIC APHERESIS AND DIALYSIS, 2003, 7 (03) : 285 - 291
[36] Outcome of stem cell transplantation for Waldenström’s macroglobulinemia: analysis of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) Lymphoma Working Group
Masatoshi Sakurai
Takehiko Mori
Hitoji Uchiyama
Hiroatsu Ago
Koji Iwato
Tetsuya Eto
Hiromi Iwasaki
Takahito Kawata
Hiroyuki Takamatsu
Satoshi Yamasaki
Minoko Takanashi
Tatsuo Ichinohe
Yoshiko Atsuta
Ritsuro Suzuki
Annals of Hematology, 2020, 99 : 1635 - 1642
[37] Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelodysplastic/Myeloproliferative Neoplasms-Unclassifiable: A Retrospective Nationwide Study of the Japan Society for Hematopoietic Cell Transplantation
Kurosawa, Shuhei
Shimomura, Yoshimitsu
Tachibana, Takayoshi
Ishiyama, Ken
Ota, Shuichi
Kobayashi, Takeshi
Uchida, Naoyuki
Fukushima, Kentaro
Ashida, Takashi
Matsuoka, Ken-ichi
Kanda, Junya
Ichinohe, Tatsuo
Atsuta, Yoshiko
Murata, Makoto
Aoki, Jun
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (09) : 1607 - 1611
[38] Multiple myeloma: Allogeneic or autologous hematopoietic stem cell transplantation?
Ghavamzadeh, A.
Kasaeian, A.
Alimoghaddam, K.
Ranjbar, H.
Mousavi, A.
Bahar, B.
Kamranzadeh, H.
Vaezi, M.
Maheriazar, R.
Jahani, M.
BONE MARROW TRANSPLANTATION, 2017, 52 : S466 - S466
[39] Multiple Myeloma: Allogeneic or Autologous Hematopoietic Stem Cell Transplantation?
Vaezi, Mohammad
Tavakkoli, Sahar
Kasaeian, Amir
Alimoghadam, Kamran
Kamranzadeh, Hosein
Mousavi, Seyed Asadillah
Ghavamzadeh, Ardeshir
BONE MARROW TRANSPLANTATION, 2018, 53 : 653 - 654
[40] Hematopoietic growth factors and autologous or allogeneic stem cell transplantation
Bay, Jacques-Olivier
De Latour, Regis Peffault
Tournilhac, Olivier
Choufi, Bachra
Chassagne, Jacques
BULLETIN DU CANCER, 2006, 93 (05) : 473 - 482

← 1 2 3 4 5 →